Niken M. Mahaweni

Tumour‐derived exosomes as antigen delivery carriers in dendritic cell‐based immunotherapy for malignant mesothelioma

Niken M. Mahaweni, Margaretha E. Kaijen-Lambers, Jacqueline Dekkers et al. · Journal of Extracellular Vesicles · 2013 · 119 citations · Full text

Life Sciences, Immunology, Oncology +17

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human

Joachim G.J.V. Aerts, Pauline L. de Goeje, Robin Cornelissen et al. · Clinical Cancer Research · 2017 · 88 citations · Full text

Life Sciences, Immunology, Oncology +16

A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism

Niken M. Mahaweni, Timo I. Olieslagers, Ivan Olivares Rivas et al. · Scientific Reports · 2018 · 60 citations · Full text

Life Sciences, Genetics, Immunology +14

Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions

Niken M. Mahaweni, Gerard M.J. Bos, Constantine S. Mitsiades et al. · Cancer Immunology Immunotherapy · 2018 · 43 citations · Full text

Medicine, Immunology, Oncology +17

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment

Niken M. Mahaweni, Femke A. I. Ehlers, Subhashis Sarkar et al. · Frontiers in Immunology · 2018 · 26 citations · Full text

Life Sciences, Immunology, Oncology +17